{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:38:44Z","timestamp":1781602724759,"version":"3.54.5"},"reference-count":55,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2008,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            We evaluated Linear Array (LA), a newly commercialized PGMY09\/11 L1 consensus primer PCR test that detects 37 human papillomavirus (HPV) genotypes by reverse line blot hybridization, for the detection of individual HPV genotypes and carcinogenic HPV and its clinical performance for detecting 2-year cumulative cervical precancer and cancer using archived specimens from the Atypical Squamous Cell of Undetermined Significance (ASCUS) and Low-Grade Squamous Intraepithelial Lesion Triage Study. LA testing was conducted on enrollment specimens from women referred because of an ASCUS Pap test. To gauge the performance of the new test, the results were compared to those of its prototype predecessor assay, Line Blot Assay (LBA), restricted to paired results (\n            <jats:italic>n<\/jats:italic>\n            = 3,335). LA testing was done masked to LBA results and clinical outcomes. The results of LA and LBA testing were compared for detection of carcinogenic HPV and clinical outcomes of cervical precancer and cancer. Overall, 50% and 55% of the women tested positive for carcinogenic HPV by LBA and LA, respectively (\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.0001). The percent agreement for carcinogenic HPV detection was 88%, percent positive agreement was 80%, and kappa was 0.76 for detection of carcinogenic HPV by the two assays. There was a significant increase in detection by LA for most of the 37 HPV genotypes targeted by both assays, including for 13 of 14 carcinogenic HPV genotypes. LA detected more multiple-genotype infections for all HPV genotypes among HPV-positive women (\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.0001) and for carcinogenic HPV genotypes among carcinogenic-HPV-positive women (\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.0001). LA was more sensitive (92.3% versus 87.1%;\n            <jats:italic>P<\/jats:italic>\n            = 0.003) and less specific (48.2% versus 54.0%;\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.0001) than LBA for 2-year cumulative cervical precancer and cancer as diagnosed by the Pathology Quality Control Group. In conclusion, we found LA to be a promising assay for the detection of HPV genotypes and carcinogenic HPV, and it may be clinically useful for the detection of cervical precancer and cancer in women with equivocal cytology.\n          <\/jats:p>","DOI":"10.1128\/jcm.01667-07","type":"journal-article","created":{"date-parts":[[2007,11,8]],"date-time":"2007-11-08T01:59:47Z","timestamp":1194487187000},"page":"109-117","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":83,"title":["Comparison of Linear Array and Line Blot Assay for Detection of Human Papillomavirus and Diagnosis of Cervical Precancer and Cancer in the Atypical Squamous Cell of Undetermined Significance and Low-Grade Squamous Intraepithelial Lesion Triage Study"],"prefix":"10.1128","volume":"46","author":[{"given":"Philip E.","family":"Castle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patti E.","family":"Gravitt","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology and Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, Maryland 21205"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Solomon","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics and Division of Cancer Prevention"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosette M.","family":"Wheeler","sequence":"additional","affiliation":[{"name":"Departments of Molecular Genetics and Microbiology and Obstetrics and Gynecology, University of New Mexico Health Sciences Center, School of Medicine, University of New Mexico, Albuquerque, New Mexico 87131"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[{"name":"National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.5.397"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(03)00413-7"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(03)00418-6"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03460040048027"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-05-0764"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.11.796"},{"key":"e_1_3_2_8_2","unstructured":"Reference deleted."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602915"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/50140-6736(07)61450-0"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01305-06"},{"key":"e_1_3_2_12_2","first-page":"1394","volume":"11","year":"2002","unstructured":"Castle, P. E., M. Schiffman, R. D. Burk, S. Wacholder, A. Hildesheim, R. Herrero, M. C. Bratti, M. E. Sherman, and A. Lorincz. 2002. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types. Cancer Epidemiol. Biomarkers Prev.11:1394-1399.","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji186"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(05)70086-3"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01145-07"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00104-06"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21955"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14955-0"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2007.02.006"},{"key":"e_1_3_2_20_2","first-page":"815","volume":"12","year":"2003","unstructured":"Ferreccio, C., M. C. Bratti, M. E. Sherman, R. Herrero, S. Wacholder, A. Hildesheim, R. D. Burk, M. Hutchinson, M. Alfaro, M. D. Greenberg, J. Morales, A. C. Rodriguez, J. Schussler, C. Eklund, G. Marshall, and M. Schiffman. 2003. A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer. Cancer Epidemiol. Biomarkers Prev.12:815-823.","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"e_1_3_2_21_2","first-page":"1129","volume":"10","year":"2001","unstructured":"Giuliano, A. R., M. Papenfuss, M. Abrahamsen, C. Denman, J. G. de Zapien, J. L. Henze, L. Ortega, E. M. Brown de Galaz, J. Stephan, J. Feng, S. Baldwin, F. Garcia, and K. Hatch. 2001. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control. Cancer Epidemiol. Biomarkers Prev.10:1129-1136.","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"e_1_3_2_22_2","first-page":"477","volume":"12","year":"2003","unstructured":"Gravitt, P. E., R. D. Burk, A. Lorincz, R. Herrero, A. Hildesheim, M. E. Sherman, M. C. Bratti, A. C. Rodriguez, K. J. Helzlsouer, and M. Schiffman. 2003. A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiol. Biomarkers Prev.12:477-484.","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.1.357-361.2000"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.10.3020-3027.1998"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1086\/428850"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.3.791-795.1997"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji187"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-1057"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.325.7364.572"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65688-X"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.14.1749"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510470070037"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0006-341X.2000.00345.x"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603843"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.44.2.571-579.2006"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-04-0230"},{"key":"e_1_3_2_37_2","first-page":"485","volume":"12","year":"2003","unstructured":"Richardson, H., G. Kelsall, P. Tellier, H. Voyer, M. Abrahamowicz, A. Ferenczy, F. Coutlee, and E. L. Franco. 2003. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol. Biomarkers Prev.12:485-490.","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(06)70731-8"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj209"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02580-06"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1159\/000328554"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2005.04.002"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.1.87"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1309\/E067X0L1U3CY37NW"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.24.3106"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/95.1.46"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22527"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.16.2114"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.4.293"},{"key":"e_1_3_2_50_2","first-page":"4","volume":"9","year":"2006","unstructured":"Stoler, M. H. 2006. HPV testing: if it's not clinically validated, it's dangerous. HPV Today9:4-5.","journal-title":"HPV Today"},{"key":"e_1_3_2_51_2","first-page":"1","volume":"127","year":"2007","unstructured":"Stoler, M. H., P. E. Castle, D. Solomon, and M. Schiffman. 2007. The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays. Am. J. Clin. Pathol.127:1-3.","journal-title":"Am. J. Clin. Pathol."},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1309\/MPERNJ0G62RECHCQ"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1086\/507909"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2007.07.047"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp020178"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000109426.82624.f8"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.01667-07","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.01667-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T06:13:04Z","timestamp":1646460784000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.01667-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["10.1128\/JCM.01667-07"],"URL":"https:\/\/doi.org\/10.1128\/jcm.01667-07","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"2007-08-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-10-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}